Species differences of serum albumins: III. Analysis of structural characteristics and ligand binding properties during N-B transitions

Pharmaceutical Research

Volumn 15, Issue 4, 1998, Pages 592-598

  Kosa, Takamitsu ^a   Maruyama, Toru ^a,b   Sakai, Norifumi ^a   Yonemura, Naoko ^a   Yahara, Shoji ^a   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

Author keywords

Chemical modification; Conformation stability; N B transition; Protein binding; Serum albumin; Species difference

Indexed keywords

DIAZEPAM; DRUG BINDING PROTEIN; IBUPROFEN; PHENYLBUTAZONE; SERUM ALBUMIN; WARFARIN;

ARTICLE; CHEMICAL MODIFICATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DOG; DRUG BINDING; DRUG CONFORMATION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SPECIES DIFFERENCE;

ANIMALS; BINDING SITES; CATTLE; DIAZEPAM; DOGS; HISTIDINE; HUMANS; HYDROGEN-ION CONCENTRATION; IBUPROFEN; LIGANDS; PHENYLBUTAZONE; PROTEIN CONFORMATION; RABBITS; RATS; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE; SPECIES SPECIFICITY; WARFARIN;

EID: 0031901772     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011986028529     Document Type: Article

References (29)

1. Part II: T. Kosa, T. Maruyama, and M. Otagiri. Species differences of serum albumins, II. The chemical and thermal stability, Pharm. Res. 15:447-452 (1998).
2. W. J. J. Leonard, K. K. Vijai, and J. F. Foster. A structural transformation in bovine and human plasma albumins in alkaline solution as revealed by rotatory dispersion studies, J. Biol. Chem. 238: 1984-1988 (1963).
3. R. Weisiger, J. Gollan, and R. Ockner. Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances, Science 211:1048-1051 (1981).
4. E. L. Forker and B. A. Luxon. Albumin-mediated transport of rose bengal by perfused rat liver. Kinetics of the reaction at the cell surface, J. Clin. Invest., 72:1764-1771 (1983).
5. E. L. Forker and B. A. Luxon. Albumin helps mediate removal of taurocholate by rat liver, J. Clin. Invest. 67:1517-1522 (1981).
6. R. K. Ockner, R. A. Weisiger, and J. L. Gollan. Hepatic uptake of albumin-bound substances: albumin receptor concept, Am. J. Physiol. 245:013-18 (1983).
7. E. L. Forker and B. A. Luxon. Hepatic uptake of propranolol [letter], Hepatology, 6:340-341 (1986).
8. B. L. Trigatti and G. E. Gerber. A direct role for serum albumin in the cellular uptake of long-chain fatty acids, Biochem. J. 308:155-159 (1995).
9. T. Horie, T. Mizuma, S. Kasai, and S. Awazu, Conformational change in plasma albumin due to interaction with isolated rat hepatocyte. Am. J. Physiol. 254:G465-470 (1988).
10. G. Sudlow, D. J. Birkett, and D. N. Wade. The characterization of two specific drug binding sites on human serum albumin, Mol. Pharmacol. 11:824-832 (1975).
11. J. H. Droge, L. H. Janssen, and J. Wilting. A study on the allosteric interaction between the major binding sites of human serum albumin using microcalorimetry, Biochim. Biophy. Acta 827:396-402 (1985).
12. O. J. Bos, M. J. Fischer, J. Wilting, and L. H. Janssen. Mechanism by which warfarin binds to human serum albumin. Stopped-flow kinetic experiments with two large fragments of albumin, Biochem. Pharmacol. 38:1979-1984 (1989).
13. J. Wilting, W. van der Giesen, L. H. Janssen, M. M. Weideman, M. Otagiri, and J. H. Perrin. The effect of albumin conformation on the binding of warfarin to human serum albumin, J. Biol. Chem. 255:3032-3037 (1980).
14. E. L. Vansterkenburg, J. Wilting, and L. H. Janssen. Influence of pH on the binding of suramin to human serum albumin, Biochem. Pharmacol., 38:3029-3035 (1989).
15. A. A. Elbary, J. J. Vallner, and C. W. Whitworth. Effect of albumin conformation on the binding of phenylbutazone and oxyphenbutazone to human serum albumin, J. Pharm. Sci. 71:241-244 (1982).
16. B. J. t' Hart, J. Wilting, and J. de Gier. Evidence for distinct consecutive steps in the neutral to base transition of human serum albumin, Biochem. Pharmacol., 35:1005-1009 (1986).
17. J. Wilting, B. J. t' Hart, and J. de Gier. The role of albumin conformation in the binding of diazepam to human serum albumin, Biochim. Biophy. Acta 626:291-298 (1980).
18. S. Wanwimolruk, and D. J. Birkett. The effects of N-B transition of human serum albumin on the specific drug-binding sites, Biochim. Biophy. Acta 709:247-255 (1982).
19. L. H. Janssen, J. H. Droge, F. C. Durlinger, and F. J. Fruytier. The pH dependence of the thermodynamics of the interaction of diazepam with human serum albumin, J. Biol. Chem. 260:11442-11445 (1985).
20. X. M. He and D. C. Carter. Atomic structure and chemistry of human serum albumin, Nature, 358:209-215 (1992).
21. J. X. Ho, E. W. Holowachuk, E. J. Norton, P. D. Twigg, and D. C. Carter. X-ray and primary structure of horse serum albumin (Equus caballus) at 0.27-nm resolution, Eur. J. Biochem. 215:205-212 (1993).
22. T. Kosa, T. Maniyama, and M. Otagiri. Species differences of serum albumins, I. Drug binding sites, Pharm. Res., 14:1608-1613 (1997).
23. J. F. Labro, and L. H. Janssen. A proton nuclear magnetic resonance study of human serum albumin in the neutral pH region, Biochim. Biophy. Acta 873:267-278 (1986).
24. J. L. Roosemont. Reaction of histidine residues in proteins with diethylpyrocarbonate: differential molar absorptivities and reactivities, Anal. Biochem. 88:314-320 (1978).
25. J. H. M. Droge, J. Willing, and L. H. M. Janssen. A comparative study of some physicochemical properties of human serum albumin samples from different sources II, The characteristics of the N-B transition and the binding behaviour with regard to warfarin and diazepam. Biochem. Pharmacol. 31:3781-3786 (1982).
26. R. L. Perlman and H. Edelhoch. The formation of diiodotyrosine in iodinated human serum albumin, J. Biol. Chem. 242:2416-2422 (1967).
27. E. S. Benson, B. E. Hallaway, and R. W. Lumry. Deuterium-hydrogen exchange analysis of pH-dependent transitions in bovine plasma albumin, J. Biol. Chem. 239:122-129 (1964).
28. E. S. Benson and B. E. Hallaway. On the mechanisms of pH-dependent hydrogen exchange of bovine plasma albumin in the range of pH 5 to 8.5, J. Biol. Chem. 245:4144-4149 (1970).
29. O. J. Bos, J. F. Labro, M. J. Fischer, J. Wilting, and L. H. Janssen. The molecular mechanism of the neutral-to-base transition of human serum albumin. Acid/base titration and proton nuclear magnetic resonance studies on a large peptic and a large tryptic fragment of albumin, J. Biol. Chem. 264:953-959 (1989).